BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27869162)

  • 21. CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.
    Yasui H; Kajiyama H; Tamauchi S; Suzuki S; Peng Y; Yoshikawa N; Sugiyama M; Nakamura K; Kikkawa F
    Clin Exp Metastasis; 2020 Feb; 37(1):145-158. PubMed ID: 31541326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II promotes ovarian cancer spheroid formation and metastasis by upregulation of lipid desaturation and suppression of endoplasmic reticulum stress.
    Zhang Q; Yu S; Lam MMT; Poon TCW; Sun L; Jiao Y; Wong AST; Lee LTO
    J Exp Clin Cancer Res; 2019 Mar; 38(1):116. PubMed ID: 30845964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KDM4B plays an important role in mitochondrial apoptosis by upregulating HAX1 expression in colorectal cancer.
    Li H; Yang X; Wang G; Li X; Tao D; Hu J; Luo X
    Oncotarget; 2016 Sep; 7(36):57866-57877. PubMed ID: 27506941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.
    Spillman MA; Manning NG; Dye WW; Sartorius CA; Post MD; Harrell JC; Jacobsen BM; Horwitz KB
    Cancer Res; 2010 Nov; 70(21):8927-36. PubMed ID: 20959477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10.
    Zheng J; Ge P; Liu X; Wei J; Wu G; Li X
    Tumour Biol; 2017 Jun; 39(6):1010428317706207. PubMed ID: 28656883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
    Desjardins M; Xie J; Gurler H; Muralidhar GG; Sacks JD; Burdette JE; Barbolina MV
    J Ovarian Res; 2014; 7():70. PubMed ID: 24999371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KDM4B down-regulation facilitated breast cancer cell stemness via PHGDH upregulation in H3K36me3-dependent manner.
    Wang XY; Li HM; Xia R; Li X; Zhang X; Jin TZ; Zhang HS
    Mol Cell Biochem; 2024 Apr; 479(4):915-928. PubMed ID: 37249813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone lysine demethylase 4B regulates general and unique gene expression signatures in hypoxic cancer cells.
    Qiu L; Meng Y; Wang L; Gunewardena S; Liu S; Han J; Krieg AJ
    MedComm (2020); 2021 Sep; 2(3):414-429. PubMed ID: 34766154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.
    Gong C; Yang Z; Wu F; Han L; Liu Y; Gong W
    Oncol Rep; 2016 Oct; 36(4):2177-83. PubMed ID: 27499367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KDM4B facilitates colorectal cancer growth and glucose metabolism by stimulating TRAF6-mediated AKT activation.
    Li H; Lan J; Wang G; Guo K; Han C; Li X; Hu J; Cao Z; Luo X
    J Exp Clin Cancer Res; 2020 Jan; 39(1):12. PubMed ID: 31931846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
    Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
    Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns.
    Loessner D; Rockstroh A; Shokoohmand A; Holzapfel BM; Wagner F; Baldwin J; Boxberg M; Schmalfeldt B; Lengyel E; Clements JA; Hutmacher DW
    Biomaterials; 2019 Jan; 190-191():63-75. PubMed ID: 30396040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KDM4B promotes DNA damage response via STAT3 signaling and is a target of CREB in colorectal cancer cells.
    Deng WW; Hu Q; Liu ZR; Chen QH; Wang WX; Zhang HG; Zhang Q; Huang YL; Zhang XK
    Mol Cell Biochem; 2018 Dec; 449(1-2):81-90. PubMed ID: 29633065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
    Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
    Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipokine Apelin/APJ Pathway Promotes Peritoneal Dissemination of Ovarian Cancer Cells by Regulating Lipid Metabolism.
    Dogra S; Neelakantan D; Patel MM; Griesel B; Olson A; Woo S
    Mol Cancer Res; 2021 Sep; 19(9):1534-1545. PubMed ID: 34172534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.
    Yokoi A; Yoshioka Y; Yamamoto Y; Ishikawa M; Ikeda SI; Kato T; Kiyono T; Takeshita F; Kajiyama H; Kikkawa F; Ochiya T
    Nat Commun; 2017 Mar; 8():14470. PubMed ID: 28262727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
    Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
    Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histone demethylase KDM4B regulates otic vesicle invagination via epigenetic control of Dlx3 expression.
    Uribe RA; Buzzi AL; Bronner ME; Strobl-Mazzulla PH
    J Cell Biol; 2015 Nov; 211(4):815-27. PubMed ID: 26598618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of MED12 Induces Tumor Dormancy in Human Epithelial Ovarian Cancer via Downregulation of EGFR.
    Luo XL; Deng CC; Su XD; Wang F; Chen Z; Wu XP; Liang SB; Liu JH; Fu LW
    Cancer Res; 2018 Jul; 78(13):3532-3543. PubMed ID: 29735544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer.
    Kastelein AW; Vos LMC; van Baal JOAM; Koning JJ; Hira VVV; Nieuwland R; van Driel WJ; Uz Z; van Gulik TM; van Rheenen J; Ince C; Roovers JWR; van Noorden CJF; Lok CAR
    Clin Exp Metastasis; 2020 Apr; 37(2):293-304. PubMed ID: 32008138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.